Aspa-KO 基因敲除小鼠

1. Wang, Dan, Tai, Phillip W L, Gao, Guangping. . Adeno-associated virus vector as a platform for gene therapy delivery. In Nature reviews. Drug discovery, 18, 358-378. doi:10.1038/s41573-019-0012-9. https://pubmed.ncbi.nlm.nih.gov/30710128/

2. Bulcha, Jote T, Wang, Yi, Ma, Hong, Tai, Phillip W L, Gao, Guangping. 2021. Viral vector platforms within the gene therapy landscape. In Signal transduction and targeted therapy, 6, 53. doi:10.1038/s41392-021-00487-6. https://pubmed.ncbi.nlm.nih.gov/33558455/

3. Wang, Jiang-Hui, Gessler, Dominic J, Zhan, Wei, Gallagher, Thomas L, Gao, Guangping. 2024. Adeno-associated virus as a delivery vector for gene therapy of human diseases. In Signal transduction and targeted therapy, 9, 78. doi:10.1038/s41392-024-01780-w. https://pubmed.ncbi.nlm.nih.gov/38565561/

4. Chao, Jianfei, Feng, Lizhao, Ye, Peng, Matalon, Reuben, Shi, Yanhong. 2022. Therapeutic development for Canavan disease using patient iPSCs introduced with the wild-type ASPA gene. In iScience, 25, 104391. doi:10.1016/j.isci.2022.104391. https://pubmed.ncbi.nlm.nih.gov/35637731/